Chugai Pharmaceutical Statistics

Total Valuation

Chugai Pharmaceutical has a market cap or net worth of JPY 10.94 trillion. The enterprise value is 10.10 trillion.

Market Cap	10.94T
Enterprise Value	10.10T

Important Dates

The next estimated earnings date is Thursday, January 30, 2025.

Earnings Date	Jan 30, 2025
Ex-Dividend Date	Jun 27, 2024

Share Statistics

Chugai Pharmaceutical has 1.65 billion shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	n/a
Shares Outstanding	1.65B
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	21.32%
Float	639.51M

Valuation Ratios

The trailing PE ratio is 28.28 and the forward PE ratio is 27.80. Chugai Pharmaceutical's PEG ratio is 3.99.

PE Ratio	28.28
Forward PE	27.80
PS Ratio	9.58
PB Ratio	6.07
P/TBV Ratio	6.15
P/FCF Ratio	31.17
P/OCF Ratio	n/a
PEG Ratio	3.99

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.66, with an EV/FCF ratio of 28.77.

EV / Earnings	26.09
EV / Sales	8.84
EV / EBITDA	17.66
EV / EBIT	18.69
EV / FCF	28.77

Financial Position

The company has a current ratio of 5.89

Current Ratio	5.89
Quick Ratio	4.67
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	67,522.25

Financial Efficiency

Return on equity (ROE) is 23.20% and return on invested capital (ROIC) is 20.24%.

Return on Equity (ROE)	23.20%
Return on Assets (ROA)	17.37%
Return on Capital (ROIC)	20.24%
Revenue Per Employee	150.23M
Profits Per Employee	50.89M
Employee Count	7,604
Asset Turnover	0.59
Inventory Turnover	1.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.70% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+24.70%
50-Day Moving Average	6,906.26
200-Day Moving Average	6,157.22
Relative Strength Index (RSI)	46.06
Average Volume (20 Days)	2,024,290

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Chugai Pharmaceutical had revenue of JPY 1.14 trillion and earned 386.96 billion in profits. Earnings per share was 235.15.

Revenue	1.14T
Gross Profit	805.18B
Operating Income	540.18B
Pretax Income	540.22B
Net Income	386.96B
EBITDA	567.09B
EBIT	540.18B
Earnings Per Share (EPS)	235.15

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	845.32B
Total Debt	n/a
Net Cash	845.32B
Net Cash Per Share	513.71
Equity (Book Value)	1.80T
Book Value Per Share	1,094.71
Working Capital	1.23T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 419.42 billion and capital expenditures -68.41 billion, giving a free cash flow of 351.01 billion.

Operating Cash Flow	419.42B
Capital Expenditures	-68.41B
Free Cash Flow	351.01B
FCF Per Share	213.31

Full Cash Flow Statement

Margins

Gross margin is 70.48%, with operating and profit margins of 47.29% and 33.87%.

Gross Margin	70.48%
Operating Margin	47.29%
Pretax Margin	47.29%
Profit Margin	33.87%
EBITDA Margin	49.64%
EBIT Margin	47.29%
FCF Margin	30.73%

Dividends & Yields

This stock pays an annual dividend of 82.00, which amounts to a dividend yield of 1.23%.

Dividend Per Share	82.00
Dividend Yield	1.23%
Dividend Growth (YoY)	1.25%
Years of Dividend Growth	2
Payout Ratio	34.45%
Buyback Yield	-0.01%
Shareholder Yield	1.22%
Earnings Yield	3.54%
FCF Yield	3.21%

Dividend Details

Stock Splits

The last stock split was on June 29, 2020. It was a forward split with a ratio of 3.

Last Split Date	Jun 29, 2020
Split Type	Forward
Split Ratio	3

Scores

Chugai Pharmaceutical has an Altman Z-Score of 23.76.

Altman Z-Score	23.76
Piotroski F-Score	n/a